Injectable gout drug draws FDA ire

Twenty-three people have died after being injected with colchicine, a gout drug that's FDA-approved only for oral use. Spurred by these reports, the FDA is cracking down on companies that sell the unapproved form.

Colchicine is a highly toxic drug, the FDA says, and overdoses are difficult to avoid when it's given intravenously. The agency gave companies 30 days to stop making injectable colchicine and 180 days to stop shipping it; after that time, FDA permits will be required for manufacturing or shipping.

- read the FDA release
- see this story for more

Suggested Articles

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

After Merck and Bayer's vericiguat scored in a heart failure trial, you'd expect potential rivals to brace themselves. Not so for Novartis'…